Potential For US Requiring Supplement Registration Underscored During FDA’s Hiatus From Inspections
Executive Summary
FDA’s pause in facility inspections could prompt draft legislation for mandatory supplement product registration. It told industry groups it’s working on language for legislation to give it a better handle on products in the market and facilities with problems, says CRN head Steve Mister.
You may also be interested in...
Consumer Health Fraud Didn’t Start With COVID-19, Senators And Witnesses Say At Hearing
“Dietary supplements are among the most poorly regulated consumer products,” CSPI policy director tells Senate Manufacturing, Trade and Consumer Protection Subcommittee. Ranking member Blumenthal says scams won’t end soon. “We’re six months into this pandemic with no end in sight.”
For Inspection Restart, US FDA Urged To Prioritize Foreign Supply Chains, Uninspected Sites
CRN “urges FDA to pay special attention to international supply chains, ingredient identity and purity validation,” and CHPA suggests it make progress on facilities it has not previously inspected.
US FDA's Consumer Health Oversight Absent From Appropriators’ Request For COVID-19 Assessment
House appropriators don’t mention the consumer health market in requesting a report on FDA’s response to COVID-19, but the agency’s frequent warnings about products marketed with unlawful claims could merit mentioning. Encouraging accelerated production of hand sanitizers while also ensuring the additional supplies are safe is another component of its COVID-19 response that could be covered in an assessment of its response to the pandemic.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: